热门资讯> 正文
Minerva Neurosciences提交2亿美元混合货架注册
2026-03-11 21:57
- Minerva Neurosciences (NERV) filed a $200M shelf registration allowing the company to offer securities from time to time.
- The offering may include common stock, preferred stock, debt securities, and warrants in various combinations.
More on Minerva Neurosciences
- Minerva Neurosciences, Inc. (NERV) Discusses Roluperidone as a Potential First Treatment for Negative Symptoms of Schizophrenia - Slideshow
- Minerva Neurosciences, Inc. (NERV) Discusses Roluperidone as a Potential First Treatment for Negative Symptoms of Schizophrenia Transcript
- Minerva Neurosciences GAAP EPS of -$25.51
- Seeking Alpha’s Quant Rating on Minerva Neurosciences
- Historical earnings data for Minerva Neurosciences
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
